Cargando…
Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132047/ https://www.ncbi.nlm.nih.gov/pubmed/21542887 http://dx.doi.org/10.1186/ar3301 |
| _version_ | 1782207776075808768 |
|---|---|
| author | Gonzalez-Gay, Miguel A Gonzalez-Juanatey, Carlos Miranda-Filloy, Jose A Martin, Javier Garcia-Unzueta, Maria T Llorca, Javier |
| author_facet | Gonzalez-Gay, Miguel A Gonzalez-Juanatey, Carlos Miranda-Filloy, Jose A Martin, Javier Garcia-Unzueta, Maria T Llorca, Javier |
| author_sort | Gonzalez-Gay, Miguel A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3132047 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31320472011-10-27 Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' Gonzalez-Gay, Miguel A Gonzalez-Juanatey, Carlos Miranda-Filloy, Jose A Martin, Javier Garcia-Unzueta, Maria T Llorca, Javier Arthritis Res Ther Letter BioMed Central 2011 2011-04-27 /pmc/articles/PMC3132047/ /pubmed/21542887 http://dx.doi.org/10.1186/ar3301 Text en Copyright ©2011 BioMed Central Ltd |
| spellingShingle | Letter Gonzalez-Gay, Miguel A Gonzalez-Juanatey, Carlos Miranda-Filloy, Jose A Martin, Javier Garcia-Unzueta, Maria T Llorca, Javier Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' |
| title | Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' |
| title_full | Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' |
| title_fullStr | Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' |
| title_full_unstemmed | Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' |
| title_short | Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' |
| title_sort | response to 'infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months' |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132047/ https://www.ncbi.nlm.nih.gov/pubmed/21542887 http://dx.doi.org/10.1186/ar3301 |
| work_keys_str_mv | AT gonzalezgaymiguela responsetoinfliximabtherapyincreasesbodyfatmassinearlyrheumatoidarthritisindependentlyofchangesindiseaseactivityandlevelsofleptinandadiponectinarandomizedstudyover21months AT gonzalezjuanateycarlos responsetoinfliximabtherapyincreasesbodyfatmassinearlyrheumatoidarthritisindependentlyofchangesindiseaseactivityandlevelsofleptinandadiponectinarandomizedstudyover21months AT mirandafilloyjosea responsetoinfliximabtherapyincreasesbodyfatmassinearlyrheumatoidarthritisindependentlyofchangesindiseaseactivityandlevelsofleptinandadiponectinarandomizedstudyover21months AT martinjavier responsetoinfliximabtherapyincreasesbodyfatmassinearlyrheumatoidarthritisindependentlyofchangesindiseaseactivityandlevelsofleptinandadiponectinarandomizedstudyover21months AT garciaunzuetamariat responsetoinfliximabtherapyincreasesbodyfatmassinearlyrheumatoidarthritisindependentlyofchangesindiseaseactivityandlevelsofleptinandadiponectinarandomizedstudyover21months AT llorcajavier responsetoinfliximabtherapyincreasesbodyfatmassinearlyrheumatoidarthritisindependentlyofchangesindiseaseactivityandlevelsofleptinandadiponectinarandomizedstudyover21months |